Real-world clinical utility of Xpert MTB/RIF Ultra in the assessment of tuberculosis in a low-TB-incidence, high-resource setting
Background Tuberculosis (TB) diagnosis in the UK is impacted by delay and suboptimal culture-based microbiological confirmation rates due to the high prevalence of paucibacillary disease. We examine the real-world clinical utility of Xpert MTB/RIF Ultra (Xpert-Ultra) as a diagnostic test and biomark...
Saved in:
Main Authors: | Robert C Free, Manish Pareek, Hemu Patel, Pranabashis Haldar, Jee Whang Kim, Richard Halliwell, Nelun Perera, Gerrit Woltmann, Alison Glimour-Caunt, Raman Verma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/12/1/e002624.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stool Xpert® MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme
by: S. Kabir, et al.
Published: (2024-10-01) -
Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
by: Zaiyad G. Habib, et al.
Published: (2015-01-01) -
The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review
by: Zhiyi Li
Published: (2022-01-01) -
A Model of Tuberculosis Screening for Pregnant Women in Resource-Limited Settings Using Xpert MTB/RIF
by: Eleanor R. Turnbull, et al.
Published: (2012-01-01) -
Pretreatment attrition after rifampicin-resistant tuberculosis diagnosis with Xpert MTB/RIF or ultra in high TB burden countries: a systematic review and meta-analysis
by: Tom Decroo, et al.
Published: (2025-01-01)